等待开盘 02-05 09:30:00 美东时间
+0.347
+5.89%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Goldman Sachs analyst Duffy Fischer maintains Kronos Worldwide (NYSE:KRO) with a Sell and lowers the price target from $6 to $5.
2025-12-18 01:16
Kronos Worldwide shares are trading lower after the company reported worse-than...
2025-11-07 05:57
今日重点评级关注:韦德布什:维持Artiva Biotherapeutics"跑赢大市"评级,目标价从18美元升至23美元;巴克莱:维持Cellectis"超配"评级,目标价从4美元升至8美元
2025-10-20 10:03
Goldman Sachs analyst Duffy Fischer maintains Kronos Worldwide (NYSE:KRO) with a Sell and lowers the price target from $8.5 to $6.
2025-10-18 01:16
Kronos Worldwide, Inc. announced that it expects to release its third quarter 2025 earnings in a press release after market close on November 6, 2025, following quarter-end closing procedures. The company, a major international producer of titanium dioxide products, provided details on its upcoming earnings report and contact information for investor relations.
2025-10-14 20:15
Kronos Worldwide ( ($KRO) ) has provided an update. On September 15, 2025, Kron...
2025-09-16 04:54
Kronos Worldwide, Inc. announced plans to raise €75 million through a private offering of 9.50% Senior Secured Notes due 2029 by its subsidiary Kronos International, Inc. These notes have the same terms as the existing €351.174 million notes issued in 2024, except for issuance date and price. They will trade separately for 40 days before consolidating with existing notes. The offering is secured by the company and its subsidiaries and is intended...
2025-09-03 06:30